TY - JOUR
T1 - Suppression of IκBα expression is necessary for c-jun N-terminal kinase-mediated enhancement of Fas cytotoxicity
AU - Chang, Nan Shan
AU - Schultz, Lori
AU - Heath, John
N1 - Funding Information:
We appreciate the research support by the Guthrie Foundation for Education and Research.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2000/7/21
Y1 - 2000/7/21
N2 - The role of c-Jun N-terminal kinase (JNK) in the regulation of Fas-mediated cell death was investigated. Murine L929 fibroblasts were pretreated with anisomycin for 1 h to activate JNK, followed by exposure to anti-Fas antibodies/actinomycin D (ActD) for 16-24 h. Compared to untreated controls, the induction of JNK activation failed to raise cellular sensitivity to anti-Fas/ActD killing. Notably, a significant increase in anti-Fas/ActD killing as induced by JNK preactivation was observed in L929 cells which were engineered to suppress IκBα protein expression by antisense mRNA. Restoration of the IκBα protein level in these cells by ectopic expression of a cDNA construct abolished the JNK-increased anti-Fas/ActD killing. Despite the suppression of IκBα, no constitutive p65 (RelA) NF-κB nuclear translocation was observed in the IκBα-antisense cells. Also, inhibition of NF-κB by curcumin failed to inhibit the JNK-increased Fas cytotoxicity, suggesting that NF-κB is not involved in the observed effect. Most interestingly, culturing of L929 cells on extracellular protein matrices resulted in partial suppression of IκBα expression and constitutive JNK and p42/44 MAPK activation. Upon stimulation with anisomycin, these matrix protein-stimulated cells further exhibited reduced IκBα expression and p42/44 MAPK activation, as well as became sensitized to JNK-increased anti-Fas/ActD killing. Again, ectopic expression of IκBα in these cells abolished the enhanced anti-Fas/ActD killing effect. Together, these results indicate that suppression of IκBα expression is essential for JNK-mediated enhancement of Fas cytotoxicity. (C) 2000 Academic Press.
AB - The role of c-Jun N-terminal kinase (JNK) in the regulation of Fas-mediated cell death was investigated. Murine L929 fibroblasts were pretreated with anisomycin for 1 h to activate JNK, followed by exposure to anti-Fas antibodies/actinomycin D (ActD) for 16-24 h. Compared to untreated controls, the induction of JNK activation failed to raise cellular sensitivity to anti-Fas/ActD killing. Notably, a significant increase in anti-Fas/ActD killing as induced by JNK preactivation was observed in L929 cells which were engineered to suppress IκBα protein expression by antisense mRNA. Restoration of the IκBα protein level in these cells by ectopic expression of a cDNA construct abolished the JNK-increased anti-Fas/ActD killing. Despite the suppression of IκBα, no constitutive p65 (RelA) NF-κB nuclear translocation was observed in the IκBα-antisense cells. Also, inhibition of NF-κB by curcumin failed to inhibit the JNK-increased Fas cytotoxicity, suggesting that NF-κB is not involved in the observed effect. Most interestingly, culturing of L929 cells on extracellular protein matrices resulted in partial suppression of IκBα expression and constitutive JNK and p42/44 MAPK activation. Upon stimulation with anisomycin, these matrix protein-stimulated cells further exhibited reduced IκBα expression and p42/44 MAPK activation, as well as became sensitized to JNK-increased anti-Fas/ActD killing. Again, ectopic expression of IκBα in these cells abolished the enhanced anti-Fas/ActD killing effect. Together, these results indicate that suppression of IκBα expression is essential for JNK-mediated enhancement of Fas cytotoxicity. (C) 2000 Academic Press.
UR - http://www.scopus.com/inward/record.url?scp=0033624129&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033624129&partnerID=8YFLogxK
U2 - 10.1006/bbrc.2000.3089
DO - 10.1006/bbrc.2000.3089
M3 - Article
C2 - 10903887
AN - SCOPUS:0033624129
SN - 0006-291X
VL - 274
SP - 4
EP - 10
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -